3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Lymphoma
16
Lymphoma, Non-Hodgkin
11
Lymphoma, Large B-Cell, Diffuse
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Leukemia, Lymphocytic, Chronic, B-Cell
7
Hodgkin Disease
7
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Myeloid, Acute
6
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Small Cell Lung Carcinoma
4
Neuroblastoma
4
Burkitt Lymphoma
4
Testicular Neoplasms
3
Sarcoma
3
Lymphoma, T-Cell
3
Leukemia
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Waldenstrom Macroglobulinemia
2
Testicular Germ Cell Tumor
2
Teratoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Osteosarcoma
2
Neoplasms, Germ Cell and Embryonal
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
apatinib
3
vistusertib
2
olaparib
2
camrelizumab
2
atezolizumab
2
Ipilimumab
2
Everolimus
2
trametinib
1
toripalimab
1
tilsotolimod
1
tazemetostat
1
tazarotene
1
spartalizumab
1
seviteronel
1
sargramostim
1
sacituzumab govitecan
1
rucaparib
1
roniciclib
1
romiplostim
1
pyrotinib
1
phosphorylethanolamine
1
pemigatinib
1
pembrolizumab
1
pazopanib
1
palbociclib
1
niraparib
1
magrolimab
1
lenvatinib
1
irinotecan sucrosofate
1
famitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Solid Tumor
×
etoposide phosphate
×
Clear all
NCT04469530
2026-02-27
AflacST1903
Emory University
Phase 2
Recruiting
55 enrolled